Covered recipient · General Payments record
LLANYEE I LIWANPO
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2025
$1,133.83
- Reported across 31 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.31 | 8 |
| Consulting Fee | $175.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $175.00 | 1 |
| Abbott Laboratories | $54.17 | 3 |
| Insulet Corporation | $50.82 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $32.08 | 1 |
| Alexion Pharmaceuticals, Inc. | $25.56 | 1 |
| Novo Nordisk AS | $24.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.72 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240914489 | CMS |
| Abbott Laboratories | $23.07 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240924715 | CMS |
| Abbott Laboratories | $17.38 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240950264 | CMS |
| Alexion Pharmaceuticals, Inc. | $25.56 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202968824 | CMS |
| Amgen Inc. | $175.00 | 08/22/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1226882225 | CMS |
| Insulet Corporation | $17.33 | 02/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207065376 | CMS |
| Insulet Corporation | $33.49 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207101191 | CMS |
| Novo Nordisk Inc | $24.68 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188326280 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $32.08 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181719029 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.